Price Alert

Bone Biologics Corporatio... (BBLG)

NASDAQ: BBLG · Real-Time Price · USD

2.23

-0.12 (-5.11%)

At close: Aug 15, 2025, 3:50 PM

Bone Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	2.75M	3.33M	3.57M	2.33M	3.23M	3.03M	4.45M	7.01M	6.19M	7.54M	5.06M	5.45M	5.81M	6.68M	3.37K	4.44K	71.17K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	328.84K	328.84K	n/a	n/a	n/a	579.91K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	-328.84K	-328.84K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	415.5K	n/a	n/a	n/a	328.84K	328.84K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	49.02K	n/a	n/a
Total Current Assets	3.16M	3.86M	4.07M	3.19M	3.84M	3.74M	4.98M	7.62M	6.78M	8.5M	5.2M	5.66M	6.09M	6.68M	52.39K	4.44K	71.17K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	3.16M	3.86M	4.07M	3.19M	3.84M	3.74M	4.98M	7.62M	6.78M	8.5M	5.2M	5.66M	6.09M	6.68M	52.39K	4.44K	71.17K
Account Payables	n/a	373.04K	190.06K	231.87K	146.19K	360.66K	1.1M	1.69M	2.28M	104.79K	799.48K	70.64K	54.91K	99.91K	70.28K	84.24K	503.34K
Deferred Revenue	n/a	n/a	n/a	44.98K	n/a	n/a	n/a	n/a	n/a	783.67K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.77M	12.49M	11.92M
Other Current Liabilities	251.16K	4.67K	83.34K	7.66K	18.44K	470.74K	80.51K	241.16K	1.73M	1.66M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	251.16K	377.71K	273.4K	284.51K	164.63K	831.4K	1.18M	1.93M	4.01M	2.55M	799.48K	70.64K	54.91K	99.91K	15.18M	14.62M	14.2M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.41M	2.13M	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.41M	2.13M	2.27M
Total Liabilities	251.16K	377.71K	273.4K	284.51K	164.63K	831.4K	1.18M	1.93M	4.01M	2.55M	799.48K	70.64K	54.91K	99.91K	15.18M	14.62M	14.2M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.77M	12.49M	11.92M
Common Stock	3.27K	2.95K	2.1K	1.31K	1.02K	534.00	3.13K	3.13K	16.7K	15.3K	10.35K	10.35K	10.35K	10.35K	12.27K	30.68K	30.68K
Retained Earnings	-86.04M	-85.02M	-83.5M	-82.56M	-81.77M	-80.91M	-79.36M	-77.44M	-75.67M	-71.96M	-72.85M	-71.63M	-71.17M	-70.48M	-70.3M	-69.79M	-69.3M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	2.91M	3.48M	3.79M	2.91M	3.67M	2.91M	3.79M	5.69M	2.77M	5.95M	4.4M	5.59M	6.04M	6.58M	-15.13M	-14.62M	-14.12M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a